MedTrace Logo

Wound Healing Effects of HO/03/03 In Patients With Diabetic Neuropathic Plantar and Venous Ulcers, Pilot Study.

NCT00338923 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2007-08-17

No results posted yet for this study

Summary

This is a multicenter pilot study to assess the healing effects of HO/03/03 on diabetic neuropathic plantar and venous ulcers.

HO/03/03 action mechanism involves the manipulation of keratinocyte and fibroblast migration and differentiation at the wound area.

* The primary end point of this study is assessment of safety in treating with HO/03/03 and the efficacy of the drug to promote wound closure of chronic wounds.
* The secondary end points are assessment time to closure and healing rate for the measurement of wound healing progression.

Conditions

  • Diabetic Foot Ulcer
  • Venous Ulcer

Interventions

DRUG

HO/03/03

Sponsors & Collaborators

  • HealOr

    lead INDUSTRY

Principal Investigators

  • Micha Rapoport, Dr. · Assaf Harofe Medical Center

  • Leon Gilead, Dr. · Hadassah Ein Kerem Medical Center

  • Zvi Landau, Dr. · Kaplan Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Completion
2007-05-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00338923 on ClinicalTrials.gov